Who owns NOVOZYMES AS/FI?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NVZMF from SEC Form 13F filings across 2 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 2 institutions disclosed 270,900 shares of NOVOZYMES AS/FI worth $17.2M — about 0.1% of shares outstanding; the largest disclosed holder is SCOPUS ASSET MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
2
13F holders
$17.2M
value, 2026 filers
0.1%
of shares outstanding (270,900 sh)
1
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of NVZMF's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | SCOPUS ASSET MANAGEMENT, L.P.NEW | 270,250 | $17.2M | 0.5% | 0.1% | new |
| 2 | TRUST CO OF VERMONT | 650 | $42,322 | 0.0% | 0% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.